AI assistant
HERBALIFE LTD. — Director's Dealing 2021
Feb 16, 2021
32337_dirs_2021-02-16_92e7557b-df76-43ce-b8a3-61e736e2b696.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HERBALIFE NUTRITION LTD. (HLF)
CIK: 0001180262
Period of Report: 2021-02-11
Reporting Person: LEVY ROBERT (EVP, WW Affairs & Latin Am.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-11 | Common Stock | M | 41666 | $26.645 | Acquired | 570774 | Direct |
| 2021-02-11 | Common Stock | F | 30538 | $56.66 | Disposed | 540236 | Direct |
| 2021-02-16 | Common Stock | S | 11128 | $55.4606 | Disposed | 529108 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-11 | Stock Appreciation Rights | $26.645 | M | 41666 | Disposed | 2021-05-18 | Common Stock (41666) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: This transaction was executed in multiple trades at prices ranging from $55.12 to $55.74. The price reported reflects the weighted average sale price of $55.4606. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering
20,833 shares at an exercise price of $53.29 per share.
F4: The SARS were granted on May 18, 2011. 20% vested on May 18, 2012, 20% vested on May 18, 2013 and the remaining 60% vested on May 18, 2014.